You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《大行報告》花旗升康哲藥業(00867.HK)評級至「買入」 目標價上調至26元
阿思達克 03-18 10:13
花旗發表研報,將康哲藥業(00867.HK)評級由「中性」上調至「買入」,預期醫學美容業務將維持表現強勁,與大健康業務一同成為未來新增長引擎。

康哲藥業上月宣布收購皮膚線專業公司Luqa Ventures全部股權,該行指出,公司已獨立發展皮膚科及醫學美容業務,預期將繼續投資以加強產品線,未來幾年料持續增聘人手,並拓展美容院、分銷商、電商平台等銷售渠道。

花旗指,公司目前每年取得5種創新藥物授權,包括今年計劃在中國推出癲癇用噴劑等,預期將持續為收入帶來貢獻,目標價由11.1元升至26元。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account